^
BIOMARKER:

KRAS wild-type

i
Other names: KRAS, KRAS proto-oncogene GTPase, KRAS1, KRAS2, NS, NS3, OES, CFC2, RALD, K-Ras, RASK2, KI-RAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, K-Ras 2, C-K-RAS, c-Ki-ras, c-Ki-ras2, Kirsten rat sarcoma viral oncogene homolog
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
Related biomarkers:
KRAS wild-type
Rectal Cancer
panitumumab
Sensitive
:
A2
KRAS wild-type
Colon Cancer
panitumumab
Sensitive
:
A2
KRAS wild-type
Colon Cancer
cetuximab
Sensitive
:
A2
KRAS wild-type
Rectal Cancer
cetuximab
Sensitive
:
A2
KRAS wild-type
Ovarian Cancer
VS-6766 + VS-6063
Sensitive
:
B
KRAS wild-type
Pancreatic Ductal Adenocarcinoma
gemcitabine + albumin-bound paclitaxel
Sensitive
:
B
KRAS wild-type
Pancreatic Ductal Adenocarcinoma
5-fluorouracil + oxaliplatin
Sensitive
:
B
KRAS wild-type
Colorectal Cancer
cetuximab + palbociclib
Sensitive
:
C2
KRAS wild-type
Colorectal Cancer
cetuximab
Sensitive
:
C2
KRAS wild-type
Colorectal Cancer
bevacizumab
Sensitive
:
C2
KRAS wild-type
Biliary Tract Cancer
panitumumab
Sensitive
:
C2
KRAS wild-type
Colorectal Cancer
CPGJ-602
Sensitive
:
C2
KRAS wild-type
Colorectal Cancer
panitumumab
Sensitive
:
C2
KRAS wild-type
Colorectal Cancer
cetuximab
Resistant
:
C3
KRAS wild-type
Colorectal Cancer
panitumumab + cabozantinib tablet
Sensitive
:
C3
KRAS wild-type
Colorectal Cancer
SIRB
Sensitive
:
C3
KRAS wild-type
Pancreatic Ductal Adenocarcinoma
durvalumab + CP-675206
Sensitive
:
C3
KRAS wild-type
Colorectal Cancer
MM-121
Sensitive
:
D